
    
      A randomized, open label, two treatment, two period, two sequence, single dose, crossover
      bioequivalence study of Fluoxetine Hydrochloride Delayed-Release capsules 90 mg of Dr.
      Reddy's laboratories limited, Generics, India and ProzacÂ®weekly 90 mg delayed release
      capsules of Eli Lilly and company, USA in healthy adult human subjects under fed conditions.
    
  